» Articles » PMID: 29625461

Allogeneic IPSC-Derived RPE Cell Graft Failure Following Transplantation Into the Subretinal Space in Nonhuman Primates

Overview
Specialty Ophthalmology
Date 2018 Apr 7
PMID 29625461
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To characterize the intraocular immune response following transplantation of iPS-derived allogeneic RPE cells into the subretinal space of non-immune-suppressed rhesus macaques.

Methods: GFP-labeled allogeneic iPS-derived RPE cells were transplanted into the subretinal space of one eye (n = 6), and into the contralateral eye 1 day to 4 weeks later, using a two-stage transretinal and transscleral approach. Retinas were examined pre- and post-surgery by color fundus photography, fundus autofluorescence, and optical coherence tomography (OCT) imaging. Animals were euthanized between 2 hours and 7 weeks following transplantation. T-cell (CD3), B-cell (CD20), and microglial (Iba1) responses were assessed immunohistochemically.

Results: Cells were delivered into the subretinal space in all eyes without leakage into the vitreous. Transplanted RPE cells were clearly visible at 4 days after surgery but were no longer detectable by 3 weeks. In localized areas within the bleb containing transplanted cells, T- and B-cell infiltrates and microglia were observed in the subretinal space and underlying choroid. A T-cell response predominated at 4 days, but converted to a B-cell response at 3 weeks. By 7 weeks, few infiltrates or microglia remained. Host RPE and choroid were disrupted in the immediate vicinity of the graft, with fibrosis in the subretinal space.

Conclusions: Engraftment of allogeneic RPE cells failed following transplantation into the subretinal space of rhesus macaques, likely due to rejection by the immune system. These data underscore the need for autologous cell sources and/or confirmation of adequate immune suppression to ensure survival of transplanted RPE cells.

Citing Articles

Subretinal microglia support donor photoreceptor survival in rd1 mice.

Ren Q, Lu F, Hao R, Chen Y, Liang C Stem Cell Res Ther. 2024; 15(1):436.

PMID: 39563450 PMC: 11575076. DOI: 10.1186/s13287-024-04052-0.


Large animal model species in pluripotent stem cell therapy research and development for retinal diseases: a systematic review.

Bellingrath J, Li K, Aziz K, Izzi J, Liu Y, Singh M Front Ophthalmol (Lausanne). 2024; 4:1377098.

PMID: 39253560 PMC: 11381226. DOI: 10.3389/fopht.2024.1377098.


Immunosuppression in stem cell clinical trials of neural and retinal cell types: A systematic review.

Gowrishankar S, Smith M, Creber N, Muzaffar J, Borsetto D PLoS One. 2024; 19(7):e0304073.

PMID: 38968328 PMC: 11226136. DOI: 10.1371/journal.pone.0304073.


Cell therapy for retinal degenerative disorders: a systematic review and three-level meta-analysis.

Khaboushan A, Ebadpour N, Moghadam M, Rezaee Z, Kajbafzadeh A, Zolbin M J Transl Med. 2024; 22(1):227.

PMID: 38431596 PMC: 10908175. DOI: 10.1186/s12967-024-05016-x.


Recent Progress in Retinal Pigment Epithelium Cell-Based Therapy for Retinal Disease.

Klymenko V, Gonzalez Martinez O, Zarbin M Stem Cells Transl Med. 2024; 13(4):317-331.

PMID: 38394392 PMC: 11016854. DOI: 10.1093/stcltm/szae004.


References
1.
Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S . Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors. Stem Cell Reports. 2016; 7(4):619-634. PMC: 5063628. DOI: 10.1016/j.stemcr.2016.08.011. View

2.
Rodriguez-Crespo D, Di Lauro S, Singh A, Garcia-Gutierrez M, Garrosa M, Pastor J . Triple-layered mixed co-culture model of RPE cells with neuroretina for evaluating the neuroprotective effects of adipose-MSCs. Cell Tissue Res. 2014; 358(3):705-16. DOI: 10.1007/s00441-014-1987-5. View

3.
Li Y, Tsai Y, Hsu C, Erol D, Yang J, Wu W . Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Mol Med. 2012; 18:1312-9. PMC: 3521789. DOI: 10.2119/molmed.2012.00242. View

4.
Buchholz D, Pennington B, Croze R, Hinman C, Coffey P, Clegg D . Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium. Stem Cells Transl Med. 2013; 2(5):384-93. PMC: 3667566. DOI: 10.5966/sctm.2012-0163. View

5.
Shirai H, Mandai M, Matsushita K, Kuwahara A, Yonemura S, Nakano T . Transplantation of human embryonic stem cell-derived retinal tissue in two primate models of retinal degeneration. Proc Natl Acad Sci U S A. 2015; 113(1):E81-90. PMC: 4711854. DOI: 10.1073/pnas.1512590113. View